News
Issued by PMGC Capital LLC, not Alaunos Therapeutics, Inc.
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
May 14, 2025 · Published on GlobeNewswire
It isn’t one of Alaunos Therapeutics, Inc.’s news releases, so 6ix doesn’t show it on Alaunos Therapeutics, Inc.’s page or send it as an alert.